Recruitment of African Americans to National Oncology Clinical Trials Through a Clinical Trial Shared Resource

Overview

Journal J Health Care Poor Underserved

Publisher Johns Hopkins University Press

Date 2010 Feb 23

PMID 20173284

Citations 25

Authors

Debra Wujcik

Steven N Wolff

Affiliations

Soon will be listed here.

Abstract

In 2000, using National Institutes of Health/National Cancer Institute (NIH/NCI) U54 funds, a clinical trials shared resource was established at Nashville General Hospital at Meharry to attract more African Americans to national cancer clinical trials. This Report from the Field describes the model used to achieve this end.

Citing Articles

Closing the gap: proposing a socio-ecological framework to make cancer clinical trials more accessible, equitable, and acceptable to adolescents and young adults.

Ahmad Z, Venkataraman V, Markwart M, Abrams A, Temel J, Perez G Oncologist. 2024; 29(11):918-921.

PMID: 39331472 PMC: 11546816. DOI: 10.1093/oncolo/oyae257.

Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial.

Marup F, Peters C, Nielsen S, Nygaard L, Madsen B, Mose F Kidney Int Rep. 2024; 9(8):2399-2409.

PMID: 39156169 PMC: 11328543. DOI: 10.1016/j.ekir.2024.05.006.

Strategies for increasing accrual in cancer clinical trials: What is the evidence?.

Michaels M, Weiss E, Sae-Hau M, Illei D, Lilly B, Szumita L Cancer Med. 2024; 13(10):e7298.

PMID: 38770644 PMC: 11106681. DOI: 10.1002/cam4.7298.

"Lord Knows What's Being Done with My Blood!": Black Women's Perceptions of Biospecimen Donation for Clinical Research in the United States.

Brown K, Thomas S, Brothers R, Liao Y J Racial Ethn Health Disparities. 2024; .

PMID: 38714639 DOI: 10.1007/s40615-024-02015-y.

Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement.

Thakur N, Lovinsky-Desir S, Appell D, Bime C, Castro L, Celedon J Am J Respir Crit Care Med. 2021; 204(3):e26-e50.

PMID: 34347574 PMC: 8513588. DOI: 10.1164/rccm.202105-1210ST.

References

Khaliq W, Gross M, Thyagarajan B, Jones-Webb R . What motivates minorities to participate in research?. Minn Med. 2003; 86(10):39-42. View

Doescher M, Saver B, Franks P, Fiscella K . Racial and ethnic disparities in perceptions of physician style and trust. Arch Fam Med. 2000; 9(10):1156-63. DOI: 10.1001/archfami.9.10.1156. View

Bruner D, Jones M, Buchanan D, Russo J . Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol. 2006; 24(14):2209-15. DOI: 10.1200/JCO.2005.04.8116. View

Mills E, Seely D, Rachlis B, Griffith L, Wu P, Wilson K . Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006; 7(2):141-8. DOI: 10.1016/S1470-2045(06)70576-9. View

Grann V, Jacobson J, Troxel A, Hershman D, Karp J, Myers C . Barriers to minority participation in breast carcinoma prevention trials. Cancer. 2005; 104(2):374-9. DOI: 10.1002/cncr.21164. View

Lin C, Schwaderer K, Morgenlander K, Ricci E, Hoffman L, Martz E . Factors associated with patient navigators' time spent on reducing barriers to cancer treatment. J Natl Med Assoc. 2008; 100(11):1290-7. DOI: 10.1016/s0027-9684(15)31507-8. View

Gross C, Filardo G, Mayne S, Krumholz H . The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer. 2004; 103(3):483-91. DOI: 10.1002/cncr.20792. View

Klabunde C, Springer B, Butler B, White M, Atkins J . Factors influencing enrollment in clinical trials for cancer treatment. South Med J. 2000; 92(12):1189-93. DOI: 10.1097/00007611-199912000-00011. View

Sateren W, Trimble E, Abrams J, Brawley O, Breen N, Ford L . How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002; 20(8):2109-17. DOI: 10.1200/JCO.2002.08.056. View

10.

Lara Jr P, Higdon R, Lim N, Kwan K, Tanaka M, Lau D . Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001; 19(6):1728-33. DOI: 10.1200/JCO.2001.19.6.1728. View

11.

Kaluzny A, Brawley O, Shaw J, Godley P, Warnecke R, Ford L . Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst. 1993; 85(23):1945-50. DOI: 10.1093/jnci/85.23.1945. View

12.

Boulware L, Cooper L, Ratner L, LaVeist T, Powe N . Race and trust in the health care system. Public Health Rep. 2003; 118(4):358-65. PMC: 1497554. DOI: 10.1093/phr/118.4.358. View

13.

Kornblith A, Kemeny M, Peterson B, Wheeler J, Crawford J, Bartlett N . Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer. 2002; 95(5):989-96. DOI: 10.1002/cncr.10792. View

14.

Hudson S, Momperousse D, Leventhal H . Physician perspectives on cancer clinical trials and barriers to minority recruitment. Cancer Control. 2005; 12 Suppl 2:93-6. DOI: 10.1177/1073274805012004S14. View

15.

Royal C, Baffoe-Bonnie A, Kittles R, Powell I, Bennett J, Hoke G . Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol. 2001; 10(8 Suppl):S68-77. DOI: 10.1016/s1047-2797(00)00194-0. View

16.

Farmer D, Jackson S, Camacho F, Hall M . Attitudes of African American and low socioeconomic status white women toward medical research. J Health Care Poor Underserved. 2007; 18(1):85-99. DOI: 10.1353/hpu.2007.0008. View

17.

Harris Y, Gorelick P, Samuels P, Bempong I . Why African Americans may not be participating in clinical trials. J Natl Med Assoc. 1996; 88(10):630-4. PMC: 2608128. View

18.

Comis R, Miller J, Aldige C, Krebs L, Stoval E . Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003; 21(5):830-5. DOI: 10.1200/JCO.2003.02.105. View

19.

Kemeny M, Peterson B, Kornblith A, Muss H, Wheeler J, Levine E . Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol. 2003; 21(12):2268-75. DOI: 10.1200/JCO.2003.09.124. View

20.

Adams-Campbell L, Ahaghotu C, Gaskins M, Dawkins F, Smoot D, Polk O . Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol. 2004; 22(4):730-4. DOI: 10.1200/JCO.2004.03.160. View